We are live on ! Find out more
PLXP

PLx Pharma Inc. Common Stock

Delisted

PLXP was delisted on the 12th of April, 2023.

4 hedge funds and large institutions have $161 invested in PLx Pharma Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% less funds holding

Funds holding: 344 (-30)

97% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 31

100% less capital invested

Capital invested by funds: $478K → $161 (-$477K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
-30
Holders Change %
-88.24%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
31
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
26
Wells Fargo
California
-$986 -7,577 Closed
CWM
27
Cranbrook Wealth Management
Michigan
-$976 -7,500 Closed
Osaic Holdings
28
Osaic Holdings
Arizona
-$889 -6,850 Closed
Group One Trading
29
Group One Trading
Illinois
-$665 -5,110 Closed
NA
30
NewEdge Advisors
Louisiana
-$559 -4,300 Closed
Simplex Trading
31
Simplex Trading
Illinois
-$332 -2,224 -96%

PLXP Hedge Fund Activity: Q2 2023 in Review

4 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q2 2023, worth a combined $161 — down 100% from $478K a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of PLXP and 1 opened new positions — a net loss of 30 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Baader Bank Aktiengesellschaft, opening a new position worth an estimated $2.63K. The largest seller was Park West Asset Management, exiting entirely with an estimated $192K sold.

  • 4 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q2 2023, down from 34 in Q1 2023.
  • Funds reported $161 of PLx Pharma Inc. Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 1 fund opened new PLx Pharma Inc. Common Stock positions in Q2 2023 and 31 closed out, a net change of -30 holders.
  • The largest PLx Pharma Inc. Common Stock buyer in Q2 2023 was Baader Bank Aktiengesellschaft, an estimated $2.63K added.
  • The largest PLx Pharma Inc. Common Stock seller in Q2 2023 was Park West Asset Management, an estimated $192K sold.

Based on aggregated 13F filings for Q2 2023.